Istituto Dermopatico dell'Immacolata IDI-IRCCS

Roma 00167

0 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic NRAS-mutant Melanoma, Epidermolysis Bullosa, Hidradenitis Suppurativa, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome, Netherton Syndrome

Studies at this site

• Natural History of Netherton Syndrome — Stopped early
• IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma — Completed
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome — Stopped early
• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa — Completed
• Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa — Completed